02 August 2018
Visiongain has launched a new pharma report Augmented Reality & Virtual Reality in Healthcare Market Report : Forecasts by Component (Hardware, Software), Hardware (Head Mounted Display, Heads Up Display, Glasses, Console, Others), Technology (Augmented Reality, Virtual Reality), AR Application (Surgical, Rehabilitation, Training & Medical Education), VR Application (Rehabilitation, Simulation, Diagnostic, Pain Distraction) and Geography, with Profiles of Leading Companies in the AR & VR in Healthcare Market
Virtual and Augmented reality is a suite of hardware, software and service components allowing end-users to visualize and experience virtual environments in real-time. Virtual reality (VR) is an artificial, computer-generated simulation or recreation of a real life environment or situation. It immerses the user by making them feel like they are experiencing the simulated reality first-hand, primarily by stimulating their vision and hearing. Virtual Reality major components include hardware, software and services to provide a virtual environment of real or imaginary subject and further interact with them.
Whereas augmented reality (AR) is a technology that layers computer-generated enhancements atop an existing reality in order to make it more meaningful through the ability to interact with it. AR is developed into apps and used on mobile devices to blend digital components into the real world in such a way that they enhance one another, but can also be told apart easily. In other words, AR includes hardware, software and services to overlay the real-world surrounding with subjects generated through computer generated image. Augmented reality and virtual reality are inverse reflections of one in another with what each technology seeks to accomplish and deliver for the user. Virtual reality offers a digital recreation of a real life setting, while augmented reality delivers virtual elements as an overlay to the real world.
The lead analyst for this report says:
“The study provides ecosystem analysis in order to identify the various participants in the industry along with their role in the ecosystem. It also includes Porter’s five forces analysis, which determines the degree of competition in the market by analysing the bargaining power of buyers and suppliers, as well as the threat of new entrants and substitute products. The market attractiveness tool has been used to analyse the attractiveness of the application segments under consideration.”
The Global market is highly competitive with many different players entering the market. The report discusses products from leading companies in the market. Notable companies in the Augmented Reality & Virtual Reality in Healthcare market include CAE Healthcare, WorldViz, TheraSim, Inc., GE Healthcare., EON Reality, Intuitive Surgical, Inc., Hologic, Inc., LAYAR BV and Siemens Healthineers.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.
31 January 2023
The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.
31 January 2023
The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.
31 January 2023
The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.